Molbio Diagnostics IPO Allotment Today: Check Status as GMP Signals Strong Listing
The allotment for Molbio Diagnostics IPO is set for finalization today, August 13, following a massive 70.26x subscription. Investors can check their status online as the grey market premium suggests a positive debut on the stock exchanges.
Key takeaways
- Molbio Diagnostics IPO allotment is expected to be finalized today, August 13.
- The issue was oversubscribed by over 70 times, indicating high investor interest.
- The current Grey Market Premium (GMP) of ₹156 suggests a strong listing on August 17.
- Investors can check status via Kfin Technologies using PAN or Application number.
The allotment for Molbio Diagnostics IPO is set for finalization today, August 13, following a massive 70.26x subscription. Investors can check their status online as the grey market premium suggests a positive debut on the stock exchanges.
Investors who applied for the Molbio Diagnostics IPO can expect the share allotment process to be finalized today, August 13. The public issue received an overwhelming response from the market, being oversubscribed 70.26 times by the close of the bidding period. This high demand indicates a competitive allocation process for retail and institutional investors alike.
How to Check Allotment Status
The registrar for the Molbio Diagnostics IPO is Kfin Technologies Limited. Investors can verify their allotment status by visiting the Kfin Technologies portal or the official websites of the BSE and NSE. You will typically need your PAN card number, application number, or DP ID to access the results. Once the allotment is finalized, the company will initiate refunds for unsuccessful bidders on August 14, while shares will be credited to the demat accounts of successful applicants by August 16.
Grey Market Premium and Listing Expectations
Market sentiment remains bullish for Molbio Diagnostics. As of today, the Grey Market Premium (GMP) is hovering around ₹156. The GMP is an unofficial indicator of the premium investors are willing to pay over the issue price before the shares officially list. Based on the current GMP and the strong subscription numbers, analysts expect a robust debut when the shares list on the exchanges, scheduled for August 17.
What This Means for Retail Investors
The 70.26x subscription means that the chances of receiving a full allotment are slim for most retail applicants due to the lottery-based system used for oversubscribed issues. If you are allotted shares, the current grey market trends suggest a potential for listing gains. However, investors should remember that GMP is not a guaranteed indicator of listing day performance and should focus on the company's long-term fundamentals.
- Allotment Date: August 13
- Refund Initiation: August 14
- Demat Credit: August 16
- Listing Date: August 17
This report is for informational purposes only and does not constitute financial or investment advice.
Frequently asked questions
Where can I check the Molbio Diagnostics IPO allotment status?
You can check the status on the Kfin Technologies website (the registrar) or the BSE/NSE websites using your PAN or application number.
What happens if I don't get an allotment?
If you are not allotted shares, the refund process will be initiated on August 14, and the blocked funds in your bank account will be released.
When will Molbio Diagnostics shares list on the stock exchange?
The shares are scheduled to be listed on the BSE and NSE on August 17.